期刊文献+

稳定性心绞痛的规范介入治疗 被引量:3

Regulate the Interventional Treatment in the Stable Angina
暂未订购
导出
摘要 慢性稳定性心绞痛的介入治疗目前还存在争议,国内、外相关指南及循证医学资料显示:慢性稳定性心绞痛低危患者强化药物治疗在减少缺血事件方面与介入治疗效果相同;对中、高危患者冠状动脉介入治疗可能从中获益。本文从慢性稳定性心绞痛定义、临床特点、循证医学证据、危险评估及冠状动脉介入治疗指征等方面详细阐述了稳定性心绞痛介入治疗策略。 The interventional treatment in the chronic stable angina is still controversial at present. The domestic and foreign relevant guidelines and the documents from evidence--based medicine show the treatment effects on strengthening drug therapy were the same as those of interventional treatment in reducing ischemic events in the patients at low risk in the chronic stable angina. Furthermore, the patients at mediate and high risk may benefit from coro- nary interventional treatment more than strengthening drug therapy. In this paper, the interventional treatment strategies on the stable angina were elaborated in details in the following several aspects including its definition, clinical characteris- tics, evidence--based medical evidence, risk assessment, indications of the coronary interventional treatment, and so on.
机构地区 解放军第
出处 《医学与哲学(B)》 2012年第8期8-12,共5页 Medicine & Philosophy(B)
关键词 稳定性心绞痛 临床特点 缺血证据 危险评估 介入治疗 stable angina, clinical features, ischemia evidence, risk assessment, interventional treatment
  • 相关文献

参考文献10

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2190
  • 2Stergiopoulos K, Brown D L. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease~ meta--analysis of randomized controlled trials[J]. Arch Intern Med,2012,172(4):312- 319.
  • 3Shaw L J, Berman D S, Maron D J, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ische- mic burden: results from the Clinical Outcomes Utilizing Revascu- larization and Aggressive Drug Evaluation (COURAGE) trial nu- clear substudy[J].Circulation, 2008,117(10) : 1283 - 1291.
  • 4Weintraub W S, Spertus J A, Kolm P, et al. Effect of PCI on qual- ity of life in patients with stable coronary disease[J].N Engl J Med, 2008,359(7) :677-687.
  • 5Myers W O, Davis K, Foster E D, et al. Surgical survival in the Coronary Artery Surgery Study (CASS) registry[J].Ann Thorac Surg, 1985,40(3) : 245 - 260.
  • 6经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-25. 被引量:554
  • 7中华医学会心血管病学分会介人心脏病学组,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南2012(简本)[J].中华心血管病杂志,2012,40(4):271-277.
  • 8Serruys P W, Morice M C, Kappetein A P, et al. Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Severe Coronary Artery Disease[J].N Eng J Med,2009,360:961 -972.
  • 9Task Force on Myocardial Revascularization of the European Socie- ty of Cardiology (ESC) and the European Association for Cardio-- Thoracic Surgery (EACTS), European Association for Percutane- ous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guide lines on myocardial revascularization [J]. Eur Heart J, 2010, 31 (20) :2501-2555.
  • 10心血管疾病介入诊疗技术管理规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(2):76-78. 被引量:15

二级参考文献51

  • 1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
  • 2Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 3Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 4Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 5Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 6Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 7O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 8Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 9Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 10Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.

共引文献2751

同被引文献16

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部